AstraZeneca does data deal
January 13, 2012Sales and Marketing AstraZeneca, IMS Health, data
AstraZeneca has signed a deal with an information company in a bid to improve the data it has on how …
Tracy Baker moves to MSI Consultancy
January 13, 2012Medical Communications MSI Consultancy
MSI Consultancy has appointed former Novartis manager Tracy Baker as a new consultant. Tracy has over seven years of sales …
Novartis to cut 2,000 US jobs
January 13, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts
Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …
Pharma unprepared for annus horribilis
January 12, 2012Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma
A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …
Glide Pharma appoints Dr Ian Smith as its new chief executive
January 12, 2012Business Services, Manufacturing and Production, Sales and Marketing
Glide Pharma, a firm focused on the needle-free administration of solid dose therapeutics and vaccines, has appointed Dr Ian Smith …
NICE rejects Sanofi’s Jevtana
January 12, 2012Sales and Marketing Jevtana, NICE, Sanofi, Zytiga
NICE is not recommending Sanofi’s prostate cancer drug Jevtana due to its high cost and questions over its safety. In …
Merck facility reborn as science park
January 11, 2012Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland
A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …
NICE guidance to be enforced, says Lansley
January 11, 2012Sales and Marketing NHS, NICE, PCTs, black lists, prescribing
Local NHS organisations will no longer be allowed to ‘ban’ drugs recommended by NICE, the health secretary has said.England’s primary …
Crisis in the boardroom: 2011’s most dramatic departures
January 11, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management
In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …
Janssen signs deal with rising star Forma
January 11, 2012Research and Development Forma, Janssen, alliance
Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …
Richard Barker joins Aegate as a senior advisor
January 11, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aegate, Richard Barker
Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a …
Sanofi to collaborate with UCSF on diabetes research
January 11, 2012Research and Development RNA interference, Sanofi, UCSF, academic alliance, diabetes
The University of California, San Francisco (UCSF) and Sanofi are to launch a new collaboration in diabetes research, focusing on …
Allergan plans $350m expansion of Irish plant
January 10, 2012Manufacturing and Production Allergan, Ireland
Allergan has announced plans to invest $350 million in an expansion of its manufacturing facility in County Mayo, Ireland, a …
Underwhelming results for GSK’s Relovair
January 10, 2012Research and Development, Sales and Marketing Advair, COPD, GSK, Relovair, Seretide, asthma
GlaxoSmithKline says it is on track to file its respiratory drug Relovair in Europe and the US despite mixed results …
NICE set to reject Xarelto in AF
January 10, 2012Sales and Marketing AF, NICE, Pradaxa, Xarelto, atrial fibrillation
NICE says it needs more data on Bayer’s Xarelto in order to recommend it for people with atrial fibrillation. The …
USP takes aim at supply chain security for medicines
January 10, 2012Manufacturing and Production US Pharmacopoeial Convention, USP, supply chains
The US Pharmacopoeial Convention (USP) has published the draft of a new general chapter designed to lay out best practices …
Scientists make drug delivery smooth as silk
January 10, 2012Manufacturing and Production Silk, manufacturing, microneedles
Researchers in the US have developed a new drug delivery system based on silk, which could allow drugs and vaccines …
Andrew Roberts joins Apodi senior management team
January 10, 2012Business Services, Sales and Marketing Andrew Roberts
Apodi has bolstered its senior management team with the arrival of Andrew Roberts as director of Business and Partnership Development. …
Study supports GLP-1 agonists for weight loss
January 10, 2012Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Sanofi, diabetes, lilly
An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …
Shire signs strategic partnership deal with ICON
January 10, 2012Research and Development ICON, Shire
Contract research organisation ICON has signed a strategic partnership with Shire Specialty Pharmaceuticals to be the sole global provider of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
